Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids

Dendritic cells (DCs) and macrophages are professional antigen-presenting cells (APCs) that play key roles in both innate and adaptive immunity. ChemR23 is an orphan G protein–coupled receptor related to chemokine receptors, which is expressed specifically in these cell types. Here we present the characterization of chemerin, a novel chemoattractant protein, which acts through ChemR23 and is abundant in a diverse set of human inflammatory fluids. Chemerin is secreted as a precursor of low biological activity, which upon proteolytic cleavage of its COOH-terminal domain, is converted into a potent and highly specific agonist of ChemR23, the chemerin receptor. Activation of chemerin receptor results in intracellular calcium release, inhibition of cAMP accumulation, and phosphorylation of p42–p44 MAP kinases, through the Gi class of heterotrimeric G proteins. Chemerin is structurally and evolutionary related to the cathelicidin precursors (antibacterial peptides), cystatins (cysteine protease inhibitors), and kininogens. Chemerin was shown to promote calcium mobilization and chemotaxis of immature DCs and macrophages in a ChemR23-dependent manner. Therefore, chemerin appears as a potent chemoattractant protein of a novel class, which requires proteolytic activation and is specific for APCs.

[1]  M. Baggiolini Chemokines in pathology and medicine , 2001, Journal of internal medicine.

[2]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[3]  M. Parmentier,et al.  Functional characterization of a human receptor for neuropeptide FF and related peptides , 2001, British journal of pharmacology.

[4]  D. Verbanac,et al.  Chemotactic and protease‐inhibiting activities of antibiotic peptide precursors , 1993, FEBS letters.

[5]  S. Schiffmann,et al.  The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54* , 2001, The Journal of Biological Chemistry.

[6]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[7]  Gerold Schuler,et al.  Dendritic Cells as Vectors for Therapy , 2001, Cell.

[8]  B. O'dowd,et al.  Orphan G protein-coupled receptors in the CNS. , 2001, Current opinion in pharmacology.

[9]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[10]  R. Doms,et al.  ChemR23, a putative chemoattractant receptor, is expressed in monocyte‐derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV‐1 strains , 1998, European journal of immunology.

[11]  L. Suva,et al.  1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast‐supporting stromal cells , 1999, Journal of cellular biochemistry.

[12]  A. Methner,et al.  Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands , 2002, Genome Biology.

[13]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[14]  A. Methner,et al.  A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development. , 1997, Biochemical and biophysical research communications.

[15]  O. Chertov,et al.  The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity , 2001, Cellular and Molecular Life Sciences CMLS.

[16]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[17]  G. Clayman,et al.  Chemokines in cancer , 2001, Expert Reviews in Molecular Medicine.

[18]  S. Rees,et al.  A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.

[19]  P. Roques,et al.  HIV‐1 co‐receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV‐1 primary isolates , 2000, Clinical and experimental immunology.

[20]  D. Im Orphan G protein-coupled receptors and beyond. , 2002, Japanese journal of pharmacology.

[21]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[22]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[23]  P. Allavena,et al.  Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo , 2001, European journal of immunology.

[24]  C. Caux,et al.  REGULATION OF DENDRITIC CELL RECRUITMENT BY CHEMOKINES , 2002, Transplantation.

[25]  H. Jacobe,et al.  Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. , 1997, The Journal of investigative dermatology.

[26]  R Bonecchi,et al.  Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.

[27]  S. Costagliola,et al.  Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. , 1998, Journal of immunology.

[28]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[29]  A. Barrett,et al.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. , 1986, The Biochemical journal.

[30]  P. Allavena,et al.  Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma* , 2002, The Journal of Biological Chemistry.